St. Jude Medical Announces Launch And First US Implants Of MultiPoint Pacing Technology

St. Jude Medical, Inc. , a global medical device company, recently received U.S. Food and Drug Administration (FDA) approval of the company’s proprietary, first-to-market MultiPoint Pacing technology and today announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news